Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid's CTA analysis equips physicians with critical information designed to enable precision medicine. Elucid is the first non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall. Elucid's unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs.
Company Details
- Employees
- 125
- Founded
- -
- Address
- 399 Boylston St,
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- elucidbio.com
- Keywords
- cardiovascular, plaque characterization, FFRct, CCTA, Heart Disease, CT Angiography, CCT, Stroke, Heart Attck.
- HQ
- Boston, Massachusetts
Elucid Questions
Elucid's website is elucidbio.com
Elucid's LinkedIn profile is https://www.linkedin.com/company/elucid-inc
Elucid has
125 employees.
View email and phone details for 125
employees at Elucid.
Elucid's industry is
Medical Equipment Manufacturing
Elucid's top competitors are
Elucid,
Irhythm Technologies, Inc.,
Heartflow,
Viz.ai,
Medtronic,
Inari Medical,
Rapidai,
Shockwave Medical,
Cleerly,
Aidoc.
Elucid's categories are Medical Equipment Manufacturing
Elucid's founding year is 2013
